FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387296891> ?p ?o ?g. }

• W4387296891 abstract "The Neonatal Task Force of the International Liaison Committee on Resuscitation (ILCOR) makes practice recommendations for the care of newborn infants in the delivery room (DR). ILCOR recommends that all infants who are gasping, apnoeic, or bradycardic (heart rate < 100 per minute) should be given positive pressure ventilation (PPV) with a manual ventilation device (T-piece, self-inflating bag, or flow-inflating bag) via an interface. The most commonly used interface is a face mask that encircles the infant's nose and mouth. However, gas leak and airway obstruction are common during face mask PPV. Nasal interfaces (single and binasal prongs (long or short), or nasal masks) and laryngeal mask airways (LMAs) may also be used to deliver PPV to newborns in the DR, and may be more effective than face masks.To determine whether newborn infants receiving PPV in the delivery room with a nasal interface compared to a face mask, laryngeal mask airway (LMA), or another type of nasal interface have reduced mortality and morbidity. To assess whether safety and efficacy of the nasal interface differs according to gestational age or ventilation device.Searches were conducted in September 2022 in CENTRAL, MEDLINE, Embase, Epistemonikos, and two trial registries. We searched conference abstracts and checked the reference lists of included trials and related systematic reviews identified through the search.We included randomised controlled trials (RCTs) and quasi-RCT's that compared the use of nasal interfaces to other interfaces (face masks, LMAs, or one nasal interface to another) to deliver PPV to newborn infants in the DR.Each review author independently evaluated the search results against the selection criteria, screened retrieved records, extracted data, and appraised the risk of bias. If they were study authors, they did not participate in the selection, risk of bias assessment, or data extraction related to the study. In such instances, the study was independently assessed by other review authors. We contacted trial investigators to obtain additional information. We completed data analysis according to the standards of Cochrane Neonatal, using risk ratio (RR) and 95% confidence Intervals (CI) to measure the effect of the different interfaces. We used fixed-effect models and the GRADE approach to assess the certainty of the evidence.We included five trials, in which 1406 infants participated. They were conducted in 13 neonatal centres across Europe and Australia. Each of these trials compared a nasal interface to a face mask for the delivery of respiratory support to newborn infants in the DR. Potential sources of bias were a lack of blinding to treatment allocation of the caregivers and investigators in all trials. The evidence suggests that resuscitation with a nasal interface in the DR, compared with a face mask, may have little to no effect on reducing death before discharge (typical risk ratio (RR) 0.72, 95% CI 0.47 to 1.13; 3 studies, 1124 infants; low-certainty evidence). Resuscitation with a nasal interface may reduce the rate of intubation in the DR, but the evidence is very uncertain (RR 0.68, 95% CI 0.54 to 0.85; 5 studies, 1406 infants; very low-certainty evidence). The evidence is very uncertain for the rate of intubation within 24 hours of birth (RR 0.97, 95% CI 0.85 to 1.09; 3 studies, 749 infants; very low-certainty evidence), endotracheal intubation outside the DR during hospitalisation (RR 1.15, 95% CI 0.93 to 1.42; 1 study, 144 infants; very low-certainty evidence) and cranial ultrasound abnormalities (intraventricular haemorrhage (IVH) grade ≥ 3, or periventricular leukomalacia; RR 0.94, 95% CI 0.55 to 1.61; 3 studies, 749 infants; very low-certainty evidence). Resuscitation with a nasal interface in the DR, compared with a face mask, may have little to no effect on the incidence of air leaks (RR 1.09, 95% CI 0.85 to 1.09; 2 studies, 507 infants; low-certainty evidence), or the need for supplemental oxygen at 36 weeks' corrected gestational age (RR 1.06, 95% CI 0.8 to 1.40; 2 studies, 507 infants; low-certainty evidence). We identified one ongoing study, which compares a nasal mask to a face mask to deliver PPV to infants in the DR. We did not identify any completed trials that compared nasal interfaces to LMAs or one nasal interface to another.Nasal interfaces were found to offer comparable efficacy to face masks (low- to very low-certainty evidence), supporting resuscitation guidelines that state that nasal interfaces are a comparable alternative to face masks for providing respiratory support in the DR. Resuscitation with a nasal interface may reduce the rate of intubation in the DR when compared with a face mask. However, the evidence is very uncertain. This uncertainty is attributed to the use of a new ventilation system in the nasal interface group in two of the five trials. As such, it is not possible to differentiate separate, specific effects related to the ventilation device or to the interface in these studies." @default.
• W4387296891 created "2023-10-04" @default.
• W4387296891 creator A5022698172 @default.
• W4387296891 creator A5029521134 @default.
• W4387296891 creator A5041821959 @default.
• W4387296891 creator A5059074538 @default.
• W4387296891 date "2023-10-03" @default.
• W4387296891 modified "2023-10-16" @default.
• W4387296891 title "Nasal interfaces for neonatal resuscitation" @default.
• W4387296891 cites W1915986091 @default.
• W4387296891 cites W1979301478 @default.
• W4387296891 cites W1992659712 @default.
• W4387296891 cites W2013956563 @default.
• W4387296891 cites W2016619395 @default.
• W4387296891 cites W2018428498 @default.
• W4387296891 cites W2034436295 @default.
• W4387296891 cites W2041365171 @default.
• W4387296891 cites W2044089148 @default.
• W4387296891 cites W2046224781 @default.
• W4387296891 cites W2049064105 @default.
• W4387296891 cites W2076675994 @default.
• W4387296891 cites W2114107405 @default.
• W4387296891 cites W2115097591 @default.
• W4387296891 cites W2119309196 @default.
• W4387296891 cites W2138376497 @default.
• W4387296891 cites W2144797640 @default.
• W4387296891 cites W2154619925 @default.
• W4387296891 cites W2165287844 @default.
• W4387296891 cites W2171308080 @default.
• W4387296891 cites W2225267203 @default.
• W4387296891 cites W2335218128 @default.
• W4387296891 cites W2509128696 @default.
• W4387296891 cites W2615154296 @default.
• W4387296891 cites W3081356922 @default.
• W4387296891 cites W3094026763 @default.
• W4387296891 cites W3121648575 @default.
• W4387296891 cites W3168408070 @default.
• W4387296891 cites W4205949396 @default.
• W4387296891 cites W4211052611 @default.
• W4387296891 cites W4240453675 @default.
• W4387296891 cites W4387296891 @default.
• W4387296891 doi "https://doi.org/10.1002/14651858.cd009102.pub2" @default.
• W4387296891 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37787113" @default.
• W4387296891 hasPublicationYear "2023" @default.
• W4387296891 type Work @default.
• W4387296891 citedByCount "1" @default.
• W4387296891 crossrefType "journal-article" @default.
• W4387296891 hasAuthorship W4387296891A5022698172 @default.
• W4387296891 hasAuthorship W4387296891A5029521134 @default.
• W4387296891 hasAuthorship W4387296891A5041821959 @default.
• W4387296891 hasAuthorship W4387296891A5059074538 @default.
• W4387296891 hasConcept C105922876 @default.
• W4387296891 hasConcept C127413603 @default.
• W4387296891 hasConcept C141071460 @default.
• W4387296891 hasConcept C168563851 @default.
• W4387296891 hasConcept C17744445 @default.
• W4387296891 hasConcept C187212893 @default.
• W4387296891 hasConcept C189708586 @default.
• W4387296891 hasConcept C199539241 @default.
• W4387296891 hasConcept C200457457 @default.
• W4387296891 hasConcept C2776006263 @default.
• W4387296891 hasConcept C2778165595 @default.
• W4387296891 hasConcept C2778311950 @default.
• W4387296891 hasConcept C2779473830 @default.
• W4387296891 hasConcept C2779547634 @default.
• W4387296891 hasConcept C2780843067 @default.
• W4387296891 hasConcept C42219234 @default.
• W4387296891 hasConcept C71924100 @default.
• W4387296891 hasConcept C78519656 @default.
• W4387296891 hasConceptScore W4387296891C105922876 @default.
• W4387296891 hasConceptScore W4387296891C127413603 @default.
• W4387296891 hasConceptScore W4387296891C141071460 @default.
• W4387296891 hasConceptScore W4387296891C168563851 @default.
• W4387296891 hasConceptScore W4387296891C17744445 @default.
• W4387296891 hasConceptScore W4387296891C187212893 @default.
• W4387296891 hasConceptScore W4387296891C189708586 @default.
• W4387296891 hasConceptScore W4387296891C199539241 @default.
• W4387296891 hasConceptScore W4387296891C200457457 @default.
• W4387296891 hasConceptScore W4387296891C2776006263 @default.
• W4387296891 hasConceptScore W4387296891C2778165595 @default.
• W4387296891 hasConceptScore W4387296891C2778311950 @default.
• W4387296891 hasConceptScore W4387296891C2779473830 @default.
• W4387296891 hasConceptScore W4387296891C2779547634 @default.
• W4387296891 hasConceptScore W4387296891C2780843067 @default.
• W4387296891 hasConceptScore W4387296891C42219234 @default.
• W4387296891 hasConceptScore W4387296891C71924100 @default.
• W4387296891 hasConceptScore W4387296891C78519656 @default.
• W4387296891 hasIssue "10" @default.
• W4387296891 hasLocation W43872968911 @default.
• W4387296891 hasLocation W43872968912 @default.
• W4387296891 hasOpenAccess W4387296891 @default.
• W4387296891 hasPrimaryLocation W43872968911 @default.
• W4387296891 hasRelatedWork W129841288 @default.
• W4387296891 hasRelatedWork W1987014297 @default.
• W4387296891 hasRelatedWork W2033113791 @default.
• W4387296891 hasRelatedWork W2410227055 @default.
• W4387296891 hasRelatedWork W2413356366 @default.
• W4387296891 hasRelatedWork W3102637104 @default.
• W4387296891 hasRelatedWork W3204495404 @default.
• W4387296891 hasRelatedWork W4213023968 @default.

• next